Abstract

In recent years, artificial intelligence has made remarkable strides, improving various aspects of our daily lives. One notable application is in intelligent chatbots that use deep learning models. These systems have shown tremendous promise in the medical sector, enhancing healthcare quality, treatment efficiency, and cost-effectiveness. However, their role in aiding disease diagnosis, particularly chronic conditions, remains underexplored. Addressing this issue, this study employs large language models from the GPT series, in conjunction with deep learning techniques, to design and develop a diagnostic system targeted at chronic diseases. Specifically, performed transfer learning and fine-tuning on the GPT-2 model, enabling it to assist in accurately diagnosing 24 common chronic diseases. To provide a user-friendly interface and seamless interactive experience, we further developed a dialog-based interface, naming it Chat Ella. This system can make precise predictions for chronic diseases based on the symptoms described by users. Experimental results indicate that our model achieved an accuracy rate of 97.50% on the validation set, and an area under the curve (AUC) value reaching 99.91%. Moreover, conducted user satisfaction tests, which revealed that 68.7% of participants approved of Chat Ella, while 45.3% of participants found the system made daily medical consultations more convenient. It can rapidly and accurately assess a patient’s condition based on the symptoms described and provide timely feedback, making it of significant value in the design of medical auxiliary products for household use.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.